[Effect of sodium nucleinate on the clinical and immunological indicators in infectious-allergic bronchial asthma].
D000276:Adjuvants, Immunologic; D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008231:Lymphopenia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use*; D011749:Pyrogens / Q000627:therapeutic use*; D012313:RNA / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D007369:Interferon Inducers; D009696:Nucleic Acids; D011749:Pyrogens; D012313:RNA; C013683:sodium nucleinate
Vliianie nukleinata natriia na kliniko-immunologicheskie pokazateli u bol'nykh infektsionno-allergicheskoĭ bronkhial'noĭ astmoĭ.